Form Bio Co. Ltd. (377220) — Strategic Asset Allocation Index
Form Bio Co. Ltd. (377220) has a Strategic Asset Allocation Index of 74.7% as of September 2024. Strategic assets (PP&E of ₩46.28 Billion plus long-term investments of ₩-) total ₩46.28 Billion, measured against net assets of ₩61.95 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Form Bio Co. Ltd. to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Form Bio Co. Ltd. Strategic Asset Allocation Index (2020–2022)
This chart shows how Form Bio Co. Ltd.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2024, the index stands at 74.7%, representing strategic assets of ₩46.28 Billion against net assets of ₩61.95 Billion KRW. See Form Bio Co. Ltd. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Form Bio Co. Ltd. (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Form Bio Co. Ltd. from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Form Bio Co. Ltd..
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 37.9% | ₩33.31 Billion | ₩33.31 Billion | ₩- | ₩87.96 Billion | ▲ +13.8 pp |
| 2021 | 24.1% | ₩20.33 Billion | ₩20.33 Billion | ₩- | ₩84.43 Billion | ▼ -28.9 pp |
| 2020 | 52.9% | ₩12.51 Billion | ₩12.51 Billion | ₩- | ₩23.64 Billion | — |